Liraglutide to prevent confusion after heart surgery in seniors with diabetes
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial is testing if liraglutide, a diabetes medication, can prevent delirium (sudden confusion) in older adults with type 2 diabetes who are having planned heart surgery. If you qualify, you may help find a new way to protect brain function after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older
- You have type 2 diabetes
- You are scheduled to have elective (non-emergency) heart surgery
- You do not have serious kidney or liver disease, or a history of pancreatitis
- You have not taken similar diabetes medications (like GLP-1s or SGLT2s) before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of diabetes medicine called GLP-1RA can help prevent or improve nerve damage in the heart caused by diabetes. It is for people with type 2 diabetes who are overweight or obese.
This study tests whether a GLP-1 receptor agonist (a medication used for diabetes and weight loss) can reduce heart damage during or after planned non-cardiac surgery. It may help patients with heart risk undergoing intermediate to high-risk procedures.
This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.
This study is testing two weight-loss medications: liraglutide alone or combined with orlistat. It is for adults who are overweight or obese and have certain related health conditions like high blood pressure or type 2 diabetes. The goal is to see which treatment works better for long-term weight loss.
This trial tests whether bariatric surgery or the drug liraglutide helps people with obesity lose weight and keep it off by looking at how it affects your thinking and behavior. It might help you understand which treatment works best for long-term success.
This study tests if combining exercise with a drug called liraglutide improves blood vessel health and insulin sensitivity in people with type 2 diabetes. It looks at whether these treatments work better together or alone.
Hear when a new Delirium, Postoperative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.